Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|July 9, 2021
T cells and monocyte-derived myeloid cells mediate immunotherapy-related hepatitis in a mouse modelHeather P Llewellyn, Seda Arat, Jingjin Gao, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2007
The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodiesJun Zhang, Eileen Rao, Marianna Dioszegi, et al.
Hepatology (Baltimore, Md.)|November 25, 2014
Prevention of hepatitis C virus infection and spread in human liver chimeric mice by an anti-CD81 monoclonal antibodyChanghua Ji, Yang Liu, Chandra Pamulapati, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Evaluation of secondary amide replacements in a series of CCR5 antagonists as a means to increase intrinsic membrane permeability. Part 1: Optimization of gem-disubstituted azacyclesRémy C Lemoine, Ann C Petersen, Lina Setti, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonistHanbiao Yang, Xiao-Fa Lin, Fernando Padilla, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2010
Evaluation of a 4-aminopiperidine replacement in several series of CCR5 antagonistsRémy C Lemoine, Ann C Petersen, Lina Setti, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2010
Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle seriesJutta Wanner, Lijing Chen, Rémy C Lemoine, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Evaluation of a 3-amino-8-azabicyclo[3.2.1]octane replacement in the CCR5 antagonist maravirocRémy C Lemoine, Ann C Petersen, Lina Setti, et al.
Plos One|June 2, 2015
A Linear Epitope in the N-Terminal Domain of CCR5 and Its Interaction with AntibodyBenny Chain, Jack Arnold, Samia Akthar, et al.
The Journal of Biological Chemistry|December 23, 2008
CD4-anchoring HIV-1 fusion inhibitor with enhanced potency and in vivo stabilityChanghua Ji, Erhard Kopetzki, Andreas Jekle, et al.
Pageof 5